Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression

@article{Fernandes2015EffectsOD,
  title={Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression},
  author={Brisa Fernandes and J. Hodge and J. Pasco and M. Berk and L. Williams},
  journal={Drugs & Aging},
  year={2015},
  volume={33},
  pages={21-25}
}
  • Brisa Fernandes, J. Hodge, +2 authors L. Williams
  • Published 2015
  • Medicine
  • Drugs & Aging
  • Osteoporosis is a chronic skeletal disease marked by microarchitectural deterioration of the bone matrix and depletion of bone mineral density (BMD), with a consequent increased risk for fragility fractures. It has been frequently associated with depression, which is also a chronic and debilitating disorder with high prevalence. Selective serotonin reuptake inhibitors (SSRIs), first-line agents in the pharmacological treatment of mood and anxiety disorders, have also been shown to negatively… CONTINUE READING
    Osteoimmunology and Beyond
    • 43
    • PDF
    Depression as a risk factor for fracture in women: A 10 year longitudinal study.
    • 21
    Psychiatric disorders increase complication rate after primary total knee arthroplasty.
    • 33

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 48 REFERENCES
    Antidepressant medications and osteoporosis.
    • 108
    Effect of selective serotonin reuptake inhibitors on the risk of fracture.
    • 361
    • PDF
    Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures.
    • 293
    • PDF
    Update in serotonin and bone.
    • 67
    • PDF